The Future of Peptides: Myths, Markets, and Medical Breakthroughs

SummaryThis episode covers the latest in biotech, market trends, and space innovation, featuring expert insights on peptides, new drug approvals, and SpaceX's upcoming IPO. Stay informed on cutting-edge health treatments, market strategies, and space tech developments.Chapters00:00 Tech Troubles and Market Outlook00:39 FDA Approves Eli Lilly's Oral GLP-1 Medication01:06 Introduction to Zurf and K-Beauty Trends01:44 Understanding Peptides: Myths and Realities02:38 Popular Peptides and Their Uses04:05 Peptides Approved for Specific Indications05:08 Common Peptides in Beauty and Fitness06:08 Joe Rogan and the Peptide Recovery Trend07:07 The Wild West of Peptide Market08:30 Safety and Regulation of Peptides10:22 Peptides and Cancer Risks11:17 Stem Cell Treatments Abroad12:11 Copper Peptides for Skin and Hair13:42 Market Volatility and Investment Strategies15:52 Oil Prices, Geopolitics, and Market Impact17:31 Energy Stocks and Long-term Investment20:26 Market Reactions to Tech and Telecom Stocks33:32 Eli Lilly's Oral GLP-1: A Game Changer36:04 Potential of SpaceX's IPO and Valuation43:12 SpaceX's AI Data Centers in Space45:07 Elon Musk and SpaceX's Future Visions46:52 The Big Picture: Space, Waste, and InnovationHost descriptions:Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.If you would like to join our email list, please reach out to [email protected] and let us know.